Product approvals

Explore the landscape of product approvals in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on product approvals to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Chengda Biotechnology Acquires Recombinant Quadrivalent Enterovirus Vaccine Technology for RMB 46 Million – Strengthening Its HFMD Vaccine Pipeline Beyond EV71
CompanyDeals

Chengda Biotechnology Acquires Recombinant Quadrivalent Enterovirus Vaccine Technology for RMB 46 Million – Strengthening Its HFMD Vaccine Pipeline Beyond EV71

Liaoning Chengda Biotechnology Co., Ltd. (SHA: 688739) announced that it has signed a Recombinant Quadrivalent Enterovirus Vaccine Technology Transfer Agreement with Viltech (Beijing) Biotechnology Co., Ltd. Under the agreement, Chengda…

Innovent Biologics' Xinbimin Meets Primary Endpoint in Phase III RESTORE‑3 Trial – Significant Proptosis Improvement in Chinese Patients with Inactive Thyroid Eye Disease

Innovent Biologics’ Xinbimin Meets Primary Endpoint in Phase III RESTORE‑3 Trial – Significant Proptosis Improvement in Chinese Patients with Inactive Thyroid Eye Disease

Chugai Pharmaceutical and InxMed Sign Worldwide License Agreement for SPYK04 – RAF‑MEK Molecular Glue Candidate for Solid Tumors

Chugai Pharmaceutical and InxMed Sign Worldwide License Agreement for SPYK04 – RAF‑MEK Molecular Glue Candidate for Solid Tumors

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDrug

Sichuan Huiyu Pharmaceutical’s Plerixafor Gains Marketing Approval from Italian Medicines Agency

CompanyMedical Device

Lifetech Scientific Corporation Receives NMPA Approval for Epione Navigation System

CompanyDrug

Pfizer’s RSV Vaccine Abrysvo Receives FDA Authorization for Maternal Immunization

Drug

AstraZeneca’s Forxiga Gains New Indication Approval in China for Chronic Heart Failure

CompanyMedical Device

NMPA Approves Rapid Medical Ltd’s Intracranial Thrombectomy Stent for Marketing

CompanyDrug

Innovent Biologics’ Tafolecimab Receives NMPA Approval for Hypercholesterolemia Treatment

Company

CStone Pharmaceuticals Reports 2023 Interim Financials and Business Milestones

CompanyDrug

J&J Subsidiary Janssen Wins FDA Approval for Akeega in BRCA-Positive mCRPC Treatment

Show More